Avadel Pharmaceuticals (AVDL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Avadel Pharmaceuticals

    NASDAQ: AVDL · Real-Time Price · USD
    15.76
    0.77 (5.14%)
    At close: Sep 05, 2025, 3:59 PM
    15.87
    0.70%
    After-hours: Sep 05, 2025, 07:52 PM EDT

    Avadel Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 169.12M 27.96M n/a n/a
    Cost of Revenue
    		 15.28M 846K 1.49M 815K
    Gross Profit
    		 153.84M 27.12M -1.49M -815K
    Operating Income
    		 -42.4M -137.85M -98.56M -85.55M
    Interest Income
    		 n/a n/a 11.12M 2.13M
    Pretax Income
    		 -49.08M -160.78M -111.44M -93.14M
    Net Income
    		 -48.83M -160.28M -137.46M -77.33M
    Selling & General & Admin
    		 181.04M 151.71M 74.52M 68.5M
    Research & Development
    		 15.2M 13.26M 20.7M 17.1M
    Other Expenses
    		 n/a n/a 3.35M 217K
    Operating Expenses
    		 196.24M 164.97M 95.22M 85.6M
    Interest Expense
    		 10.83M 9.89M 12.34M 9.94M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 211.52M 165.81M 95.22M 85.6M
    Income Tax Expense
    		 -247K -501K 26.02M -15.82M
    Shares Outstanding (Basic)
    		 95.14M 80.17M 60.09M 58.53M
    Shares Outstanding (Diluted)
    		 95.14M 80.17M 60.09M 58.53M
    EPS (Basic)
    		 -0.51 -2 -2.29 -1.32
    EPS (Diluted)
    		 -0.51 -2 -2.29 -1.32
    EBITDA
    		 -35.57M -149.13M -97.6M -84.78M
    EBIT
    		 -38.25M -150.89M -99.1M -83.2M
    Depreciation & Amortization
    		 2.68M 1.77M 1.49M 815K

    Add to Watchlist